PharmaCyte Biotech PMCB
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.72 | 38 | 2.04 | 1 | 1.34 | 56 |
| 2025Q3 | 0.97 | 35 | -18.82 | -7 | -14.68 | 56 |
| 2025Q2 | 1.09 | 44 | -17.51 | -8 | -16.67 | 45 |
| 2025Q1 | 1.25 | 52 | 25.50 | 12 | 23.74 | 55 |
| 2024Q4 | 1.57 | 40 | -7.28 | -3 | -6.16 | 44 |
| 2024Q3 | 1.91 | 43 | -3.23 | -1 | -2.35 | 55 |
| 2024Q2 | 1.96 | 48 | 62.16 | 23 | 36.01 | 70 |
| 2024Q1 | 2.37 | 28 | 4.56 | 1 | 2.05 | 60 |
| 2023Q4 | 2.16 | 31 | -1.82 | -1 | -0.83 | 71 |
| 2023Q3 | 2.10 | 37 | 7.02 | 3 | 3.51 | 79 |
| 2023Q2 | 2.86 | 43 | -5.52 | -3 | -4.16 | 80 |
| 2023Q1 | 2.91 | 73 | -0.17 | 0 | -0.17 | 73 |
| 2022Q4 | 2.93 | 77 | -0.97 | -1 | -0.95 | 78 |
| 2022Q3 | 2.40 | 81 | -2.25 | -2 | -2.22 | 82 |
| 2022Q2 | 2.24 | 86 | -1.75 | -2 | -1.74 | 87 |
| 2022Q1 | 2.30 | 90 | -1.57 | -1 | -1.56 | 91 |
| 2021Q4 | 2.50 | 91 | -0.88 | -1 | -0.88 | 92 |
| 2021Q3 | 3.17 | 92 | -2.00 | -1 | -1.98 | 92 |
| 2021Q2 | 6 | -16.54 | -1 | -14.60 | 7 | |
| 2021Q1 | 7 | -13.43 | -1 | -12.26 | 7 |